These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 318223)

  • 21. [Clinical studies of cefoxitin for infectious diseases in the field of obstetrics and gynecology (author's transl)].
    Endo H; Ota S; Ikeno N; Watanabe M; Shima I; Takahashi K
    Jpn J Antibiot; 1981 Jul; 34(7):1052-7. PubMed ID: 7321182
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical studies on cefoxitin in the field of obstetrics and gynecology].
    Cho N; Suzuki H; Itagaki T; Hirai N; Seki M; Kondo H; Nishimoto S; Togo M; Simizu S; Ozaki T
    Jpn J Antibiot; 1985 Feb; 38(2):212-22. PubMed ID: 4009945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of parenteral clindamycin in the treatment of obstetric-gynecologic patients with severe infections. A comparison of a clindamycin-kanamycin combination with penicillin-kanamycin.
    Ledger WJ; Kriewall TJ; Sweet RL; Fekety FR
    Obstet Gynecol; 1974 Apr; 43(4):490-7. PubMed ID: 4593619
    [No Abstract]   [Full Text] [Related]  

  • 24. Appropriate use of antibiotics in serious obstetric and gynecologic infections.
    Sweet RL; Yonekura ML; Hill G; Gibbs RS; Eschenbach DA
    Am J Obstet Gynecol; 1983 Jul; 146(6):719-39. PubMed ID: 6346880
    [No Abstract]   [Full Text] [Related]  

  • 25. Sulbactam/ampicillin versus cefoxitin in the treatment of obstetric and gynaecological infections.
    Senft HH; Stiglmayer R; Eibach HW; Koerner H
    Drugs; 1986; 31 Suppl 2():18-21. PubMed ID: 3013568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anaerobic gynecologic and obstetrical infections].
    Bygdeman M; Moberg PJ; Nord CE
    Lakartidningen; 1981 Mar; 78(13):1324-7. PubMed ID: 7218960
    [No Abstract]   [Full Text] [Related]  

  • 27. Cefoperazone therapy for obstetric and gynecologic infections.
    Strausbaugh LJ; Llorens AS
    Rev Infect Dis; 1983; 5 Suppl 1():S154-60. PubMed ID: 6221385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The penicillins.
    Campbell BA; Cox SM
    Obstet Gynecol Clin North Am; 1992 Sep; 19(3):435-47. PubMed ID: 1436922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current status of therapy with cefoxitin.
    McCloskey RV; Goren RC
    Clin Ther; 1980; 3(2):66-79. PubMed ID: 7448845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative study of cefotetan versus cefoxitin plus metronidazole in the treatment of gynecological infections.
    Schwiersch U; Lang N
    Chemioterapia; 1987 Jun; 6(2 Suppl):541-2. PubMed ID: 3334618
    [No Abstract]   [Full Text] [Related]  

  • 31. Carbapenems and penems.
    Faro S
    Obstet Gynecol Clin North Am; 1989 Jun; 16(2):271-7. PubMed ID: 2674795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical experience in the treatment of gynecologic and obstetrical infections with cefotaxime].
    Grcić R; Zivanović Z; Ivanović L; Stavrić V; Vucić V; Miscević L; Popović V; Prorocić M
    Med Pregl; 1985; 38(11-12):575-9. PubMed ID: 3835447
    [No Abstract]   [Full Text] [Related]  

  • 33. [Sisomycin sulfate in obstetric and gynecologic infections].
    Montoya Romero JD; Pérez de Salazar JL; Kunhardt Rasch J; Díaz Loya FD
    Ginecol Obstet Mex; 1981 Jan; 48(291):37-46. PubMed ID: 7274757
    [No Abstract]   [Full Text] [Related]  

  • 34. Imipenem-cilastatin.
    Dinsmoor MJ
    Obstet Gynecol Clin North Am; 1992 Sep; 19(3):475-82. PubMed ID: 1436925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cefoxitin: an overview of clinical studies in the United States.
    Neu HC
    Rev Infect Dis; 1979; 1(1):233-9. PubMed ID: 400937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cefoxitin therapy for surgical patients.
    Rambo WM; Del Bene VE; Delamar DK
    Rev Infect Dis; 1979; 1(1):195-8. PubMed ID: 318221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cefoxitin therapy in aerobic, anaerobic, and mixed aerobic-anaerobic infections.
    LeFrock JL; Schell RF; Carr BB; Kowalsky SF; Tillotson JR
    Drug Intell Clin Pharm; 1982 Apr; 16(4):306-12. PubMed ID: 7067621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aztreonam.
    Clark P
    Obstet Gynecol Clin North Am; 1992 Sep; 19(3):519-28. PubMed ID: 1436929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cefoxitin for treatment of infections due to anaerobic bacteria.
    Kirby BD; Busch DF; Citron DM; Finegold SM
    Rev Infect Dis; 1979; 1(1):113-7. PubMed ID: 318212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of cefotaxime in the treatment of obstetric and gynaecological infections.
    Soutoul JH; Quentin R; Boscq G; Chazara C; Prieur D
    J Antimicrob Chemother; 1980 Sep; 6 Suppl A():283-5. PubMed ID: 6252172
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.